November 19 – 23andMe, Inc., a privately-held personal genetics company, announced today that it has officially launched and has begun offering its services directly to consumers in the United States. 23andMe is helping individuals understand their own genetic information through the latest advances in DNA analysis and web-based interactive tools. The Company’s service will enable [...]

May 22 – 23andMe, Inc., a privately held, early stage personal genetics company today announced it had closed its Series A Preferred Stock Financing, which included investments from, among others,